Acadian Asset Management LLC Paratek Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.37 - $2.54 $146,983 - $272,508	-107,287 Reduced 43.49%	139,386 $352,000
Q4 2022 Feb 14, 2023	BUY	$1.67 - $2.51 $376,124 - $565,312	225,224 Added 1050.04%	246,673 $459,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $138,499 - $207,042	-70,663 Reduced 76.71%	21,449 $54,000
Q2 2022 Aug 09, 2022	BUY	$1.73 - $3.09 $159,353 - $284,626	92,112 New	92,112 $178,000
Q2 2021 Aug 11, 2021	SELL	$6.81 - $10.93 $102,156 - $163,960	-15,001 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$6.14 - $8.31 $92,106 - $124,658	15,001 New	15,001 $106,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.